- Growth-Hormone Axis Research
Sermorelin
Body weight, energy expenditure, liver fat, and metabolic liver disease
- Compound type
Synthetic GHRH(1-29) analog
- Research status
- Scientific overview
Overview
How it works
GHRH receptor activation: Sermorelin binds pituitary GHRH receptors and stimulates endogenous GH secretion.
Physiologic feedback: Because signaling occurs upstream of GH release, normal somatostatin/GHRH feedback remains relevant.
Downstream IGF-1 axis: Research can measure downstream changes in GH and IGF-1 signaling.
Research areas
Pituitary function
Growth-hormone stimulation research
Endocrine aging
GHRH analog pharmacology
Research / study context
Endocrine stimulation studies: Human studies use serial GH sampling and endocrine-response endpoints.
Comparative secretagogue research: Studies compare GHRH analogs with other GH secretagogues or combinations.
Key research findings
Sermorelin is a well-defined GHRH research tool.
Evidence of GH release should not be converted into broad claims about anti-aging or body composition.
Regulatory status should be described carefully and separately from historical use.
Scientific reference starter set
PubMed search: GHRH 1-29 pituitary stimulation
PubMed search: sermorelin GHRH 1-29 growth hormone
PubMed search: GHRH 1-29 pituitary stimulation
Research material
View available specifications and batch documentation in the Apex catalog.
Important
For research use only. Not for human consumption. This profile is educational and does not provide treatment or personal-use instructions.